| The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with … D Cibula, R Pötter, F Planchamp, E Avall-Lundqvist, D Fischerova, ... Virchows Archiv 472, 919-936, 2018 | 916 | 2018 |
| Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study A Sturdza, R Pötter, LU Fokdal, C Haie-Meder, LT Tan, R Mazeron, ... Radiotherapy and Oncology 120 (3), 428-433, 2016 | 657 | 2016 |
| The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies R Pötter, K Tanderup, C Kirisits, A de Leeuw, K Kirchheiner, R Nout, ... Clinical and translational radiation oncology 9, 48-60, 2018 | 543 | 2018 |
| A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy L Cozzi, KA Dinshaw, SK Shrivastava, U Mahantshetty, R Engineer, ... Radiotherapy and oncology 89 (2), 180-191, 2008 | 538 | 2008 |
| Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a … S Gupta, A Maheshwari, P Parab, U Mahantshetty, R Hawaldar, S Sastri, ... Journal of Clinical Oncology 36 (16), 1548-1555, 2018 | 395 | 2018 |
| MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study R Pötter, K Tanderup, MP Schmid, I Jürgenliemk-Schulz, C Haie-Meder, ... The Lancet Oncology 22 (4), 538-547, 2021 | 332 | 2021 |
| Dose–volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer … R Mazeron, LU Fokdal, K Kirchheiner, P Georg, N Jastaniyah, B Šegedin, ... Radiotherapy and oncology 120 (3), 412-419, 2016 | 235 | 2016 |
| Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial V Murthy, P Maitre, S Kannan, G Panigrahi, R Krishnatry, G Bakshi, ... Journal of Clinical Oncology 39 (11), 1234-1242, 2021 | 218 | 2021 |
| European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer MHM Oonk, F Planchamp, P Baldwin, M Bidzinski, M Brännström, ... International Journal of Gynecologic Cancer 27 (4), 2017 | 211 | 2017 |
| Dose–effect relationship and risk factors for vaginal stenosis after definitive radio (chemo) therapy with image-guided brachytherapy for locally advanced cervical cancer in … K Kirchheiner, RA Nout, JC Lindegaard, C Haie-Meder, U Mahantshetty, ... Radiotherapy and oncology 118 (1), 160-166, 2016 | 182 | 2016 |
| Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: an international multicenter phase II clinical trial … LK Mell, I Sirák, L Wei, R Tarnawski, U Mahantshetty, CM Yashar, ... International Journal of Radiation Oncology* Biology* Physics 97 (3), 536-545, 2017 | 155 | 2017 |
| Impact of COVID-19 on cancer care in India: a cohort study P Ranganathan, M Sengar, G Chinnaswamy, G Agrawal, R Arumugham, ... The Lancet Oncology 22 (7), 970-976, 2021 | 143 | 2021 |
| Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial S Shrivastava, U Mahantshetty, R Engineer, S Chopra, R Hawaldar, ... JAMA oncology 4 (4), 506-513, 2018 | 143 | 2018 |
| Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo) therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer … K Kirchheiner, RA Nout, K Tanderup, JC Lindegaard, H Westerveld, ... International Journal of Radiation Oncology* Biology* Physics 89 (1), 88-95, 2014 | 131 | 2014 |
| The management of locally advanced cervical cancer PN Ch, L Gurram, S Chopra, U Mahantshetty Current opinion in oncology 30 (5), 323-329, 2018 | 117 | 2018 |
| Expression profiling of cervical cancers in I ndian women at different stages to identify gene signatures during progression of the disease A Thomas, U Mahantshetty, S Kannan, K Deodhar, SK Shrivastava, ... Cancer Medicine 2 (6), 836-848, 2013 | 114 | 2013 |
| Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy V Sharma, U Mahantshetty, KA Dinshaw, R Deshpande, S Sharma International Journal of Radiation Oncology* Biology* Physics 52 (2), 310-315, 2002 | 114 | 2002 |
| Management of renal cell carcinoma with solitary metastasis YB Thyavihally, U Mahantshetty, RS Chamarajanagar, ... World Journal of Surgical Oncology 3, 1-9, 2005 | 109 | 2005 |
| Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis … K Kirchheiner, R Pötter, K Tanderup, JC Lindegaard, C Haie-Meder, ... International Journal of Radiation Oncology* Biology* Physics 94 (5), 1088-1098, 2016 | 101 | 2016 |
| ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer–Update 2023 D Cibula, MR Raspollini, F Planchamp, C Centeno, C Chargari, A Felix, ... Virchows Archiv 482 (6), 935-966, 2023 | 99 | 2023 |
